SMS Pharmaceuticals Ltd.
NSE: SMSPHARMA | BSE: 532815
₹376.25
₹7.10
(1.92%)
As on 26-May-2026IST
Market cap
₹3,530 Cr
Revenue (TTM)
₹887 Cr
P/E Ratio
34.6
P/B Ratio
4.5
Div. Yield
0.1 %
Quality Score
2/10
Growth Score
7/10
Valuation Score
3/10
Momentum Score
10/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹102 Cr
-
ROE
11.9 %
-
ROCE
12.6 %
-
Industry P/E
47.26
-
EV/EBITDA
21.4
-
Debt to Equity
0.2
-
Book Value
₹83.9
-
EPS
₹11
-
Face value
1
-
Shares outstanding
93,652,030
10 Years Aggregate
CFO
₹545.78 Cr
EBITDA
₹973.89 Cr
Net Profit
₹441.18 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
SMS Pharma
| 21.2 | -5.2 | -1.2 | 43.5 | 64.1 | 16.9 | 18.6 |
|
BSE Healthcare
| 9.2 | 8.8 | 7.8 | 11.6 | 26.7 | 14.0 | 12.1 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
SMS Pharma
| 20.9 | 99.3 | 43.4 | -35.6 | 8.2 | 183.7 | -41.0 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
SMS Pharma
|
376.3 | 3,529.8 | 886.9 | 88.0 | 14.8 | 13.5 | 34.6 | 4.5 |
| 3,034.8 | 24,824.6 | 1,339.4 | 356.4 | 33.2 | 23.2 | 69.7 | 15.0 | |
| 759.6 | 14,918.2 | 7,344.9 | 670.6 | 10.9 | 13.7 | 22.1 | 2.6 | |
| 434.9 | 16,630.2 | 2,268.6 | 150.1 | 10.6 | 5.4 | 92.8 | 4.3 | |
| 756.5 | 18,753.3 | 5,365.6 | 595.0 | 16.6 | 13.3 | 31.5 | 3.7 | |
| 985.2 | 15,693.2 | 8,279.6 | 397.8 | 9.9 | 6.4 | 39.4 | 2.2 | |
| 1,805.6 | 20,654.6 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.5 | |
| 178.9 | 23,767.0 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.9 | |
| 465.3 | 18,776.7 | 3,738.7 | 316.7 | 12.5 | 7.5 | 59.3 | 3.9 | |
| 1,700.2 | 27,687.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 130 | 5.6 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About SMS Pharma
SMS Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers anti-ulcer, anti-fungal, anti-migraine, anti-diabetic, anti-epileptic, anti-psychotic, anti-inflammatory,... anti-fungal, anti-viral, anti-coagulant, and anti-retroviral products. It is also involved in the contract research activities. The company also exports its products. SMS Pharmaceuticals Limited was incorporated in 1987 and is based in Hyderabad, India. Read more
-
Incorporated
1987
-
Chairman
Ramesh Babu Potluri
-
Managing Director
Ramesh Babu Potluri
-
Headquarters
Hyderabad, Telangana
-
Website
Looking for more details about SMS Pharmaceuticals Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for SMS Pharma
What is the current share price of SMS Pharmaceuticals Ltd Today?
The share price of SMS Pharmaceuticals Ltd is ₹376.25 (NSE) and ₹376.90 (BSE) as of 26-May-2026 IST. SMS Pharmaceuticals Ltd has given a return of 64.1% in the last 3 years.
What is the current PB & PE ratio of SMS Pharmaceuticals Ltd?
The P/E ratio of SMS Pharmaceuticals Ltd is 34.61 times as on 26-May-2026, a 27 discount to its peers’ median range of 47.26 times.
The P/B ratio of SMS Pharmaceuticals Ltd is 4.49 times as on 26-May-2026, a 16 premium to its peers’ median range of 3.86 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
27.27
|
3.02
|
|
2024
|
30.25
|
2.97
|
|
2023
|
0.00
|
1.06
|
|
2022
|
12.76
|
1.69
|
|
2021
|
16.84
|
2.57
|
What is the 52 Week High and Low of SMS Pharmaceuticals Ltd?
The 52-week high and low of SMS Pharmaceuticals Ltd are Rs 447.80 and Rs 207.70 as of 26-May-2026.
What is the market cap of SMS Pharmaceuticals Ltd?
SMS Pharmaceuticals Ltd has a market capitalisation of ₹ 3,530 Cr as on 26-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in SMS Pharmaceuticals Ltd?
Before investing in SMS Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.